
Eczacıbaşı Holding Chairperson Bülent Eczacıbaşı received his bachelor’s degree in chemistry from Imperial College London and his master’s degree in chemical engineering from the Massachusetts Institute of Technology. He began his professional career in 1974 at the Eczacıbaşı Group. He served as Chairperson of the Board of the Turkish Industry and Business Association (TÜSİAD) from 1991 to 1993, Chairperson of the High Advisory Council of TÜSİAD from 1997 to 2001, Founding Chairperson of the Board of Trustees of the Turkish Economic and Social Studies Foundation (TESEV) from 1993 to 1997, and Chairperson of the Board of the Pharmaceutical Employers’ Association of Turkey (İEİS) from 2000 to 2008.
Bülent Eczacıbaşı currently serves as Honorary Chairperson of TÜSİAD and İEİS, Honorary Member of the Foreign Economic Relations Board (DEİK), Honorary Member of the Turkish Enterprise and Business Confederation (TÜRKONFED), Member of the High Advisory Council of the Aegean Industry and Business Association (ESİAD), and Member of the High Advisory Board of TESEV.
He is also Chairperson of the Board of Trustees of the Istanbul Modern Art Foundation, which houses the Istanbul Modern Museum, of which the Eczacıbaşı Group is the founding sponsor; Chairperson of the Board of Directors of the Istanbul Foundation for Culture and Arts (IKSV), also founded with the sponsorship of the Group; and serves as Chairperson of the Board of Directors of several Eczacıbaşı Group companies.
Bülent Eczacıbaşı is the recipient of the Order of the Star of Italy (Commendatore dell'Ordine della Stella d'Italia, 2003) and the French National Order of the Legion of Honour (Chevalier dans l'Ordre National de la Légion d'Honneur, 2014).

Faruk Eczacıbaşı, who completed his undergraduate studies in business administration and economics, and his graduate studies in business administration at Technical University of Berlin, began his professional career in 1980 in the Planning Department of Eczacıbaşı Holding. After serving for a period as a product manager at Eczacıbaşı İlaç Sanayi, he joined the Group’s Padeko İlaç Sanayi in 1987, where he first served as Deputy General Manager and later as General Manager. In 1989, he founded Eczacıbaşı Bilgi İletişim A.Ş. and led the Eczacıbaşı Group’s “e-transformation” process for many years.
Appointed as Vice Chairman of the Board of Eczacıbaşı Holding in 1996, Faruk Eczacıbaşı continues to serve as Chairman and Vice Chairman of the Board in various Eczacıbaşı Group companies. In addition, he has been serving as Chairman of Eczacıbaşı Sports Club since 1999.
Through the Türkiye Bilişim Vakfı (TBV), which he chairs and which was established in 1995 with the vision of “technology for good” to support Türkiye’s transformation into an information society, he continues to contribute to the preparation of various research reports and the shaping of policies in this field.

Emin Fadıllıoğlu received his graduate degree from Cerrahpasa Medical Faculty of İstanbul University in 1991 and his MBA degree from Marmara University in 1993.
Emin Fadıllıoğlu initiated his career in 1991 as Medical Doctor at Haydarpaşa Numune Hospital. In 1996, he joined Abbott Turkey as Marketing Trainee and progressed on different roles with increasing responsibilities. Between 2002 and 2005 he worked as Area Commercial Director - Abbott Diabetes Care for Asia Pacific & Japan based in Tokyo, and then between 2005 and 2008, as Division Vice President for Europe, Middle East, Africa & India based in Frankfurt, Germany. Between 2008 and 2012, Fadıllıoğlu worked as General Manager at Abbott Turkey. Then, he served as Vice President and General Manager at GSK Pharmaceuticals Turkey between 2012 and 2017.
He is the Founder and Chairperson of the Board of the Digital Health Association (DİSADER), which was established with the goal of developing Turkey’s future digital health ecosystem on a global scale.
Emin Fadıllıoğlu has been serving as CEO of Eczacıbaşı Pharmaceutical, Industrial, and Financial Investments since 2021 and is also the founder of Eczacıbaşı Evital, the Eczacıbaşı Group’s initiative in the field of digital health.
İpek Güleç received her undergraduate degree in Quantitative Economics and International Relations from Tufts University in 2006.
Güleç started her career in 2006 as an Analyst at JPMorgan Chase Investment Banking Division in New York, focusing on mergers and acquisitions and capital restructuring in the Financial Institutions Group.
In 2007 she joined Actera Group, a leading private equity firm focusing on investments in Turkey. At Actera, she respectively assumed the roles of Analyst, Associate, Senior Associate, Vice President and Director between 2007 and 2022.
Since January 2023, Güleç serves as the Chief Investment Officer of Eczacıbaşı Holding.

Erol Ulukutlu, received his bachelor's degree in 1985 and his master's degree in Economics from Boğaziçi University in 1989.
Erol Ulukutlu, who also worked as a Project Assistant in the Department of Economics for two years during his university years, started his professional life as an Assistant Inspector at Türkiye İş Bankası in 1986. In 1990, he worked in the Treasury Planning Department at Körfez Bank. At the end of 1990, he joined Eczacıbaşı Holding as a specialist in the Budget Planning Department. He worked at Eczacıbaşı Group for 20 years between 1991-2011. During this period, he held the positions of the Chief of Budget Planning, Economic Research, Finance Manager and Finance Director at the Holding. Since 2005, he has been in the management of Eczacıbaşı Ekom Dış Ticaret Şirketi as a responsible Board member. Erol Ulukutlu took part in the Eczacıbaşı Construction Group Restructuring project in 2009 and held the position of CFO of the Construction Group in early 2010. Erol Ulukutlu left the Eczacıbaşı Group in 2011 and held the position of CFO at Kalyon İnşaat company in 2013-2014.
At the end of 2014, Erol Ulukutlu left his Corporate Governance responsibilities, and he has been supporting various companies as a Management Consultant since then.
In 2013-2014, he worked as a lecturer in Business Strategy and Finance at Aydın University. Erol Ulukutlu, one of the founders of the Corporate Risk Management Association, and after being a Board member of the Association for a long time, also served as the General Coordinator of the Association between 2015-2017.

İhsan Rifat Öktem, received his bachelor's degree from the now-known-as Anadolu University Faculty of Pharmacy. After working as a freelance pharmacist for a short time, he joined the Ministry of Health. He received his postgraduate science specialization at Ankara İTİA, his Pharmaceutical Technology Master's degree at Anadolu University Faculty of Pharmacy, and his PhD in Pharmaceutical Sciences Ankara University Faculty of Pharmacy.
Between 1978 and 1991, he worked as a specialist, branch manager, inspector, Chief inspector, General Manager, deputy undersecretary and deputy undersecretary in the Ministry of Health.
He was appointed as Ankara Representative of Eczacıbaşı Holding on 01.11.1991. He completed this duty on 31.01.2018 and retired.
He worked as a consultant in the same organization between 15.02.2018 and 30.06.2018.
Eczacıbaşı Holding A.Ş.
346.845.460,43
50,62
Eczacıbaşı Yatırım Holding Ortaklığı A.Ş.
209.803.928,39
30,62
Other (the public portion)
128.610.611,18
18,76
Total
685.260.000,00
100,00
COMPANY TYPE
JOINT STOCK COMPANY
MERSIS (CENTRAL REGISTRY SYSTEM)
326001968500011
TRADE REGISTRY OFFICE
İSTANBUL
TRADE REGISTRY NUMBER
44943
TRADE NAME
EIS ECZACIBASI PHARMACEUTICAL AND INDUSTRIAL INVESTMENT CO.
ADDRESS
Büyükdere Caddesi Ali Kaya Sokak No:5 Levent 34394, İSTANBUL
ISSUED CAPITAL
685.260.000
AUTHORIZED CAPITAL
1.920.000.000
DATE OF REGISTRY
24.10.1951
TAX OFFICE
İSTANBUL - Büyük Mükellefler Vergi Dairesi Başkanlığı
TAX NUMBER
3260019685
BUSINESS FIELD
HOLDING COMPANY FUNCTIONS (EXCLUDING THE MANAGEMENT OF AFFILIATED SUBSIDIARIES)
CONTACT INFORMATION
www.eczacibasi.com.tr ; www.eis.com.tr